Barrett Bready, CEO, Nabsys
0:00 What happened?
3:52 It’s all about structural variation today
8:16 Nanopores don’t multiplex well
11:41 Long reads now mainstream
14:25 The back story on the Nabsys reboot
17:20 "SV GWAS”
Barrett Bready is back on the program. He’s the CEO of Nabsys, a company with some new technology for genome mapping.
Originally Nabsys had been working to develop nanopore sequencing, but after a recent reboot has become focused on scaling up scientists' ability to read structural genomic information. Barrett compares Nabsys’ new multiplex technology for genome mapping to the improvement of arrays over single nucleotide (SNP) detection.
"When we first started we were using solid state nanopores. And we realized that there were limitations to nanopores. Nanopores don’t multiplex well. If you have two nanopores very close to each other and a DNA molecule goes through nanopore number one, the signal in nanopore number two will be effected. So we developed our proprietary nano-detector that can be multiplexed at really high density.”
With long read sequencing now gone mainstream coupled with a growing interest among genome scientists in structural variation, Barrett says Nabsys has a chance to enter the marketplace competing on price and throughput and will have their instrument ready for beta testing early next year.